Pharmaceutical Research

, Volume 32, Issue 8, pp 2764–2774

Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer

  • Waseem Hariri
  • Thangirala Sudha
  • Dhruba J. Bharali
  • Huadong Cui
  • Shaker A. Mousa
Research Paper

DOI: 10.1007/s11095-015-1662-x

Cite this article as:
Hariri, W., Sudha, T., Bharali, D.J. et al. Pharm Res (2015) 32: 2764. doi:10.1007/s11095-015-1662-x



Estrogen Receptor-α (ERα) expression is increased in prostate cancer and acts as an oncogene. We propose that blocking of estrogen hormone binding to ERα using the ERα blocker toremifene will reduce the tumorigenicity of prostate cancer, and nano-targeted delivery of toremifene will improve anticancer efficacy. We report the synthesis and use in an orthotopic mouse model of PLGA-PEG nanoparticles encapsulating toremifene and nanoparticles encapsulating toremifene that are also conjugated to anti-PSMA for targeted prostate tumor delivery.


Human prostate cancer cell line PC3M and a nude mouse model were used to test efficacy of nano-targeted and nano-encapsulated toremifene versus free toremifene on the growth and differentiation of tumor cells.


Treatment with free toremifene resulted in a significant reduction in growth of prostate tumor and proliferation, and its nano-targeting resulted in greater reduction of prostate tumor growth, greater toremifene tumor uptake, and enhanced tumor necrosis. Tumors from animals treated with nano-encapsulated toremifene conjugated with anti-PSMA showed about a 15-fold increase of toremifene compared to free toremifene.


Our data provide evidence that blocking ERα by toremifene and targeting prostate cancer tissues with anti-PSMA antibody on the nanoparticles’ surface repressed the tumorigenicity of prostate cancer cells in this mouse model.


anti-PSMA antibody estrogen receptor-α blocker nanomedicine nano-targeted therapy prostate cancer 



Estrogen receptor alpha


Estrogen receptor beta


High Grade Prostatic Intraepithelial Hyperplasia


3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide


Poly (ethylene glycol)


Poly (lactic-co-glycolic acid)


Prostate specific membrane antigen


Selective estrogen receptor modulator

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Waseem Hariri
    • 1
  • Thangirala Sudha
    • 1
  • Dhruba J. Bharali
    • 1
  • Huadong Cui
    • 1
  • Shaker A. Mousa
    • 1
  1. 1.The Pharmaceutical Research InstituteAlbany College of Pharmacy and Health SciencesRensselaerUSA

Personalised recommendations